Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases ...

The changing therapeutic landscape for urticaria, angioedema, and anaphylaxis is evidenced by emerging treatments reported at ...

Hanna Newnham, 27, from Brighton, first noticed symptoms of cold urticaria - hives that appear after cold temperature exposure - after recovering from Covid-19 in 2020 ...

A 27-year-old woman developed a rare cold allergy after Covid-19 and had her first anaphylaxis attack after a McDonald’s ...

Hannah started experiencing progressively worse cold-exposure symptoms including angioedema (facial swelling ... Two months after recovering from Covid-19 in April 2020, she first developed ...

Pictures of hives, also known as urticaria, can help you to identify these raised, red, itchy bumps or welts. Causes include stress, infections, food or latex allergies, medications, and environmental ...

Five years on, the onset of the coronavirus pandemic is still fresh – though the speed of the news cycle can make it feel like long ago. Some hallmarks of the pandemic era are still common ...

About 1.22 million people have died of COVID in the U.S., CDC data shows. Tuesday marks five years since the World Health Organization (WHO) declared the global outbreak of COVID-19 to be a pandemic.

Questions remain over where COVID came from and how long it spread undetected. Five years ago, the World Health Organization declared the COVID-19 outbreak to be a pandemic, leading to stay at ...

Five years after the novel coronavirus emerged, historians see echoes of other great illnesses, and legacies that are unlike any of them. Credit...Katherine Lam Supported by By Gina Kolata Five ...

Read more of our coverage of COVID’s fifth anniversary: a critical reflection on lessons learned and future pandemic preparedness; and the problem with brushing off our varied experiences of ...

J&J and Protagonist Therapeutics are collectively developing icotrokinra, which is poised to be an immunology blockbuster. Image credit: Emily frost / Shutterstock. Johnson & Johnson (J&J) and ...